- Home
- RLYB vs UCL Comparison
RLYB vs UCL Comparison
Compare RLYB & UCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | RLYB | UCL |
|---|---|---|
| Founded | 2018 | 2014 |
| Country | United States | Hong Kong |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Telecommunications Equipment |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 24.1M | 74.5M |
| IPO Year | 2021 | 2020 |
Fundamental Metrics
Financial Performance| Metric | RLYB | UCL |
|---|---|---|
| Price | $0.66 | $2.00 |
| Analyst Decision | Hold | |
| Analyst Count | 2 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 185.6K | 15.3K |
| Earning Date | 11-06-2025 | 11-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 8.06 |
| EPS | N/A | ★ 0.12 |
| Revenue | $674,000.00 | ★ $85,239,000.00 |
| Revenue This Year | $17.61 | N/A |
| Revenue Next Year | N/A | $20.86 |
| P/E Ratio | ★ N/A | $16.84 |
| Revenue Growth | ★ 12.71 | N/A |
| 52 Week Low | $0.22 | $0.80 |
| 52 Week High | $1.08 | $4.19 |
Technical Indicators
Market Signals| Indicator | RLYB | UCL |
|---|---|---|
| Relative Strength Index (RSI) | 49.41 | 50.87 |
| Support Level | $0.71 | $1.95 |
| Resistance Level | $0.80 | $2.25 |
| Average True Range (ATR) | 0.06 | 0.15 |
| MACD | -0.00 | 0.03 |
| Stochastic Oscillator | 44.06 | 41.93 |
Price Performance
Historical ComparisonAbout RLYB Rallybio Corporation
Rallybio Corp is a clinical stage biotechnology company committed to identifying and accelerating the development of life-transforming therapies for patients with severe and rare disorders. The programs of the company are for the prevention of fetal and neonatal alloimmune thrombocytopenia, a potentially life-threatening rare disease that can cause uncontrolled bleeding in fetuses and newborns.
About UCL uCloudlink Group Inc.
Ucloudlink Group Inc is engaged in the provision of data connectivity services and sales of Wi-Fi terminals and data related products to enable personal and enterprise users to access mobile internet in more than 100 countries and areas. Leveraging its inventive cloud SIM technology and architecture, the company redefine the mobile data connectivity experience, allowing users to gain access to mobile data traffic allowance shared by network operators on its marketplace. It has aggregated mobile data traffic allowances from 391 MNOs in 163 countries and regions in its cloud SIM architecture. The company derives maximum revenue from Japan.